Understanding the Role of Targets and Pathways in the Treatment Melanoma
Click here for continuing education information.
After reviewing the articles in this supplement, click on the "How to Earn Credit" link at the bottom of the page for instructions on how to take the learning assessment, complete the evaluation form, and earn credit.
This CME/CE/CPE certified supplement is jointly provided by:
Continuing Education
How to Earn Credit
Read MoreEditorial
A Letter From the Guest Editors
Lisa A. Kottschade, APRN, MSN, CNP, and LeAnn B. Norris, PharmD, FCCP, BCPS, BCOPRead MoreEditorial
A Brighter Future for Patients With Melanoma
Lisa A. Kottschade, APRN, MSN, CNP, and LeAnn B. Norris, PharmD, FCCP, BCPS, BCOPRead MoreReview Article
Diagnosis, Evaluation, and Surgical Management of Melanoma
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Christan G. Bartsch, MSHS, PA-C, MPHRead MoreReview Article
Harnessing the Immune System in the Treatment of Melanoma
Suzanne McGettigan, MSN, CRNP, AOCN®Read MoreReview Article
BRAF/MEK Inhibition in Melanoma: An Update
Lisa A. Kottschade, APRN, MSN, CNP, and Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHNRead MoreReview Article
Mutations Beyond BRAF V600
Mollie Reed, MSN, ACNP-BCRead MoreReview Article
Melanomas of Noncutaneous Origin: Diagnosis, Treatment, and Outcomes
Lisa A. Kottschade, APRN, MSN, CNPRead MoreReview Article
Supportive Care and Management of Treatment-Related Adverse Effects From Immune Checkpoint Inhibitors and Targeted Therapies in Melanoma
Krista M. Rubin, MS, FNP-BC, and Lisa A. Kottschade, APRN, MSN, CNPRead MoreReview Article
Drug-Drug Interactions in Melanoma
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOPRead MoreAppendix
Appendix
Compiled by Lisa A. Kottschade, APRN, MSN, CNPRead More